Praxis Precision Medicines, Inc. · NASDAQ:PRAX

Chodakewitz Jeffrey received 1,371 Praxis Precision Medicines, Inc. shares as an award (Form 4)

Traded Jun 10, 2026 · Filed Jun 12, 2026

On Jun 10, 2026, Chodakewitz Jeffrey (Director) received 1,371 Praxis Precision Medicines, Inc. shares as an award, leaving 1,371 shares. Filed Jun 12, 2026 (Form 4).

Awarded
1,371 shares
Holding after
1,371 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 10, 2026Common StockAward1,3711,371Direct

Source

View original at SEC

Related